These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8985971)

  • 1. Scientists confirm natural resistance to HIV-1.
    Oncology (Williston Park); 1996 Dec; 10(12):1879-80. PubMed ID: 8985971
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV type 1 coreceptors, neutralization serotypes, and vaccine development.
    Moore J; Trkola A
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):733-6. PubMed ID: 9171216
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS research. Receptor mutations help slow disease progression.
    Cohen J
    Science; 1996 Sep; 273(5283):1797-8. PubMed ID: 8815542
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploiting the HIV-chemokine nexus.
    Cohen J
    Science; 1997 Feb; 275(5304):1261-4. PubMed ID: 9064780
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethics of AIDS study.
    Gomperts ED; Donfield SM
    Science; 1996 Dec; 274(5293):1596. PubMed ID: 8984621
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis?
    Garred P
    Lancet; 1998 Jan; 351(9095):2-3. PubMed ID: 9433416
    [No Abstract]   [Full Text] [Related]  

  • 7. In search of AIDS-resistance genes.
    O'Brien SJ; Dean M
    Sci Am; 1997 Sep; 277(3):44-51. PubMed ID: 9274039
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.
    Garred P; Eugen-Olsen J; Iversen AK; Benfield TL; Svejgaard A; Hofmann B
    Lancet; 1997 Jun; 349(9069):1884. PubMed ID: 9217763
    [No Abstract]   [Full Text] [Related]  

  • 9. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Michael NL; Louie LG; Sheppard HW
    Lancet; 1997 Sep; 350(9079):741-2. PubMed ID: 9291931
    [No Abstract]   [Full Text] [Related]  

  • 10. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Smith MW; Dean M; Carrington M; Huttley GA; O'Brien SJ
    Lancet; 1997 Sep; 350(9079):741; author reply 742. PubMed ID: 9291930
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural resistance to HIV?
    Hill CM; Littman DR
    Nature; 1996 Aug; 382(6593):668-9. PubMed ID: 8751431
    [No Abstract]   [Full Text] [Related]  

  • 13. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Wang B; Palasanthiran P; Zeigler J; Cunningham A; Saksena NK
    Lancet; 1997 Sep; 350(9079):742. PubMed ID: 9291932
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance to HIV-1 infection: it's in the genes.
    Fauci AS
    Nat Med; 1996 Sep; 2(9):966-7. PubMed ID: 8782446
    [No Abstract]   [Full Text] [Related]  

  • 15. CC-chemokine receptor 5 genotypes and in vitro susceptibility to HIV-1 of a cohort of British HIV-exposed uninfected homosexual men.
    Aarons E; Fernandez M; Rees A; McClure M; Weber J
    AIDS; 1997 Apr; 11(5):688-9. PubMed ID: 9108955
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.
    Goh WC; Markee J; Akridge RE; Meldorf M; Musey L; Karchmer T; Krone M; Collier A; Corey L; Emerman M; McElrath MJ
    J Infect Dis; 1999 Mar; 179(3):548-57. PubMed ID: 9952360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines and chemokine receptors in susceptibility to HIV-1 infection and progression to AIDS.
    Chatterjee A; Rathore A; Vidyant S; Kakkar K; Dhole TN
    Dis Markers; 2012; 32(3):143-51. PubMed ID: 22377730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1-resistant individuals may lack HIV-1 coreceptor.
    Bradbury J
    Lancet; 1996 Aug; 348(9025):463. PubMed ID: 8709791
    [No Abstract]   [Full Text] [Related]  

  • 19. [Polymorphism of human alleles associated with genetic resistance against HIV-1 infection and its implications].
    Wang F; Liu D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):285-7. PubMed ID: 10932017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CCR5--the HIV co-receptor--now in Israel].
    Kantor R; Gershoni JM
    Harefuah; 1999 Nov; 137(9):405-9. PubMed ID: 11419046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.